Is a complete CSE/IAN research report available?

No complete published report is available for cse/IAN (CSE/IAN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CSE/IAN (CSE/IAN)

Canadian Securities Exchange: CSE/IAN · CAD

CA$0.01

+0.01 (+100.0%)· Recorded snapshot

Market cap	69.7M
Revenue (ttm)	197.6M
Net income (ttm)	-78.6M
EPS (ttm)	-CA$0.01
Shares out	7B
Volume	32,166
Beta	-0.72

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 197.6M
Net income (ttm): -78.6M
EPS (ttm): -CA$0.01
Market cap: 69.7M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-09-11 02:00 UTC

All CSE/IAN indicators

Market & fundamental data

Available fields

180

Groups with data

Currency

USD

Showing 180 of 180 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Employees	792
Employees Change	-42%
Employees Change Percent	-5.04
Enterprise value	CAD 397.8M
Exchange	Canadian Securities Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE Fwd	21.86
Isin	CA45074T1021
Last refreshed	2026-09-11
Market cap	CAD 69.7M
Price	CAD 0.01
Price currency	CAD
Rev Per Employee	266,654.92x
Sector	Healthcare
Sic	2834
Symbol	cse/IAN
Website	https://www.ianthus.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-112.73%
EV/EBITDA	21.07x
EV/Sales	2.01x
FCF yield	-45.62%
P/B ratio	-0.38x
P/S ratio	0.35x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-7.65%
EBITDA Margin	4.69%
Gross margin	45.05%
Gross Profit	CAD 89M
Gross Profit Growth	-13.24%
Gross Profit Growth Q	-0.33%
Gross Profit Growth3 Y	-1.79%
Gross Profit Growth5 Y	-10.4%
Net Income	CAD -78.6M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-23.32%
Profit Margin	-39.79%
Profit Per Employee	CAD -106,111
ROA	-2.53
Roa5y	-5.57
ROCE	51.36
ROIC	-5.33

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-43.44%
Cagr1y	-50.02%
Cagr3y	-47.72%
Cagr5y	-59.95%
EPS Growth Quarters	1
EPS Growth Years	0
OCF Growth Q	-75.91%
OCF Growth Qo Q	-24.95%
Revenue Growth	-10.76x
Revenue Growth Q	0.47x
Revenue Growth Qo Q	5.49x
Revenue Growth Years	0x
Revenue Growth3 Y	-2.86x
Revenue Growth5 Y	-6.3x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.53
Assets	CAD 367M
Cash	CAD 11.4M
Current Assets	CAD 64.2M
Current Liabilities	CAD 386.2M
Debt	CAD 339.5M
Debt EBITDA	CAD 17.98
Debt FCF	CAD -10.67
Equity	CAD -185.7M
Interest Coverage	-0.41
Liabilities	CAD 552.7M
Long Term Assets	CAD 302.8M
Long Term Liabilities	CAD 166.4M
Net Cash	CAD -328.1M
Net Cash By Market Cap	CAD -470
Net Debt EBITDA	CAD 35.37
Tangible Book Value	CAD -277.6M
Tangible Book Value Per Share	CAD -0.04
WACC	7.11

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.17
Inventory Turnover	3.19
Net Working Capital	CAD -42.5M
Quick ratio	0.05
Working Capital	CAD -330.5M
Working Capital Turnover	CAD -1.56

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.14%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-99.66%
1Y total return	-50%
200-day SMA	0.01
3Y total return	-85.71%
50-day SMA	0.01
50-day SMA vs 200-day SMA	50under200
5Y total return	-98.97%
All Time High	9.49
All Time High Change	-99.95%
All Time High Date	2018-09-12
All Time Low	0.01
All Time Low Change	0%
All Time Low Date	2024-11-06
ATR	0
Beta	-0.72
Beta1y	2.92
Beta2y	-1.44
High	0.01
High52	0.02
High52 Date	2025-10-30
High52ch	-33.33%
Low	0.01
Low52	0.01
Low52 Date	2026-09-10
Low52ch	100%
Ma50ch	-9.09%
Price vs 200-day SMA	-23.08%
RSI	48.13
RSI Monthly	35.5
RSI Weekly	45.07
Sharpe ratio	2.26x
Sharpe Ratio3y	1.74x
Sharpe Ratio5y	1.39x
Sortino ratio	4.97
Sortino Ratio3y	3.58
Sortino Ratio5y	2.83
Total Return	-2.14%
Tr1w	-50%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,419,457,392%
Net Borrowing	-4,900,551.8
Shares Insiders	3.79%
Shares Out	6,974,811,082
Shares Qo Q	0%
Shares Yo Y	2.14%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD -34.4M
Adjusted OCF	-4,494,617
Average Volume	55,239.2x
Bv Per Share	-0.03
CAPEX	CAD -29.9M
Ch10y	-99.66
Ch1w	-50
Ch1y	-50
Ch3y	-85.71
Ch5y	-98.97
Change	100%
Change From Open	100
Close	0.01
Days Gap	0
Depreciation Amortization	23,770,858.5
Dollar Volume	321.7
Earnings Date	2026-11-13
EBIT	CAD -15.1M
EBITDA	CAD 9.3M
EPS	CAD -0.01
F Score	1
FCF	CAD -31.8M
FCF EV Yield	-8x
FCF Per Share	CAD -0
Financing CF	-5,296,973
Fiscal Year End	December
Founded	2,014
Goodwill	2,155,578.7
Income Tax	CAD 32.6M
Investing CF	-15,018,978
Is Primary Listing	1
Last Earnings Date	2025-11-07
Last Report Date	2026-06-30
Ma150	0.01
Ma150ch	-10.71%
Ma20	0.01
Ma20ch	-9.09%
Net CF	-22,245,867
Next Earnings Date	2026-11-13
Open	0.01
Position In Range	100
Ppne	198,844,524.6
Price Date	2026-09-10
Price EBITDA	CAD 7.52
Relative Volume	0.58x
Revenue	197,591,294x
SBC By Revenue	1.3x
Share Based Comp	2,564,701
Tax By Revenue	16.48x
Volume	32,166
Z Score	-8.23

CSE/IAN (CSE/IAN)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/IAN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/IAN indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on CSE/IAN

Frequently asked questions